Home β€Ί Stock analysis β€Ί CODX

Co-Diagnostics (CODX) Latest Stock Analysis Report – Oct 15, 2026, 4:00 PM ET

Updated Oct 15, 2026, 4:00 PM ET

What changed since yesterday

CODX slides 6.5% to $0.71, a 52-week low, 3 down days in a row. Closed at $0.71, -6.54% vs the prior close of $0.76. Day range $0.71–$0.83, opened at $0.79.

Last close$0.71-6.54%
Day range0.71–0.83
Open0.79
Volume277.50K
52-week range0.71–46.50
Avg volume (20d)363.71K

CODX daily analysis β€” what happened

A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.

Oct 15, 2026 β€” CODX slides 6.5% to $0.71, a 52-week low, 3 down days in a row
Oct 14, 2026 β€” CODX slides 28.2% to $0.76, a 52-week low on 3.1x normal volume
Oct 13, 2026 β€” CODX slides 14.8% to $1.07
Oct 12, 2026 β€” CODX jumps 11.6% to $1.25, a 1-month high on 2.0x normal volume
Oct 9, 2026 β€” CODX rises 2.8% to $1.12
Oct 8, 2026 β€” CODX dips 2.7% to $1.09
Oct 7, 2026 β€” CODX dips 2.6% to $1.12
Oct 6, 2026 β€” CODX jumps 4.5% to $1.15 on 2.4x normal volume
Oct 5, 2026 β€” CODX rises 1.9% to $1.10 on 3.3x normal volume
Oct 2, 2026 β€” CODX ends flat (+0.0%) to $1.08

CODX latest news & SEC filings

Every SEC filing by or about CODX in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.

Oct 15, 2026 Β· Form 8-K β€” Major event / current report

Current report β€” a filing companies must make within 4 business days of a major event

Source: SEC EDGAR filing 0001493152-26-047242

Oct 15, 2026 Β· Form 8-K/A β€” Current report (amended)

Amended current report

Source: SEC EDGAR filing 0001493152-26-047089

Oct 13, 2026 Β· Form 8-K β€” Major event / current report

Current report β€” a filing companies must make within 4 business days of a major event

Source: SEC EDGAR filing 0001493152-26-046676

Oct 5, 2026 Β· Form 8-K β€” Major event / current report

Current report β€” a filing companies must make within 4 business days of a major event

Source: SEC EDGAR filing 0001493152-26-045652

Sep 25, 2026 Β· Form 8-K β€” Major event / current report

Current report β€” a filing companies must make within 4 business days of a major event

Source: SEC EDGAR filing 0001493152-26-044346

Sep 21, 2026 Β· Form PRE 14A β€” Preliminary proxy statement

Preliminary proxy statement

Source: SEC EDGAR filing 0001493152-26-043582

Sep 16, 2026 Β· Form 8-K β€” Major event / current report

Current report β€” a filing companies must make within 4 business days of a major event

Source: SEC EDGAR filing 0001493152-26-042854

Sep 16, 2026 Β· Form 8-K β€” Major event / current report

Current report β€” a filing companies must make within 4 business days of a major event

Source: SEC EDGAR filing 0001493152-26-042844

Sep 15, 2026 Β· Form 8-K β€” Major event / current report

Current report β€” a filing companies must make within 4 business days of a major event

Source: SEC EDGAR filing 0001493152-26-042744

Sep 14, 2026 Β· Form 3 β€” New insider holdings

Initial insider ownership statement (Form 3) β€” a new director, officer or 10% owner disclosed their holdings

Source: SEC EDGAR filing 0000912282-26-001269

Sep 4, 2026 Β· Form 8-K β€” Major event / current report

Current report β€” a filing companies must make within 4 business days of a major event

Source: SEC EDGAR filing 0001493152-26-041560

Sep 4, 2026 Β· Form DEFA14A β€” Additional proxy materials

Additional proxy materials

Source: SEC EDGAR filing 0001493152-26-041469

Sep 4, 2026 Β· Form 8-K β€” Major event / current report

Current report β€” a filing companies must make within 4 business days of a major event

Source: SEC EDGAR filing 0001493152-26-041468

Sep 1, 2026 Β· Form EFFECT β€” EFFECT filing

EFFECT filing

Source: SEC EDGAR filing 9999999995-26-002860

Aug 24, 2026 Β· Form S-3 β€” Shelf registration (S-3)

Shelf registration (S-3) β€” lets the company sell securities over time

An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.

Source: SEC EDGAR filing 0001493152-26-039875

Things to know before you trade CODX

CODX market data (last 20 sessions)

DateOpenHighLowCloseVolume
Oct 15, 20260.790.830.710.71277.50K
Oct 14, 20261.061.060.750.761.02M
Oct 13, 20261.241.251.061.07505.30K
Oct 12, 20261.121.301.111.25651.70K
Oct 9, 20261.091.131.091.12110.30K
Oct 8, 20261.131.151.081.09139.70K
Oct 7, 20261.101.141.091.12186.70K
Oct 6, 20261.121.171.051.15886.50K
Oct 5, 20261.101.211.081.101.14M
Oct 2, 20261.081.101.061.0883.40K
Oct 1, 20261.061.091.061.08141.00K
Sep 30, 20261.081.101.051.0786.90K
Sep 29, 20261.091.101.051.0798.90K
Sep 28, 20261.111.151.081.11177.00K
Sep 25, 20261.151.161.091.09189.60K
Sep 24, 20261.111.171.091.15428.40K
Sep 23, 20261.091.101.061.1084.30K
Sep 22, 20261.021.100.991.08356.80K
Sep 21, 20260.961.040.961.01300.50K
Sep 18, 20260.951.030.910.95406.60K

About Co-Diagnostics

Co-Diagnostics (CODX) is listed on the Nasdaq and classified by the SEC under β€œSurgical & Medical Instruments & Apparatus”. Its business address is in SALT LAKE CITY, UT. State of incorporation: UT. Fiscal year ends December 31. SEC CIK 1692415.

CODX board of directors & executives

From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).

Directors

NameRoleLatest filing
Eugene DurenardDirectorMay 27, 2026
Dwight H EganChief Executive OfficerMay 27, 2026
Edward L. MurphyDirectorMay 27, 2026
James B NelsonDirectorMay 27, 2026
Richard S SerbinDirectorMay 27, 2026

Executive officers

NameTitleLatest filing
Richard David AbbottPresidentMay 27, 2026
Daniel BohrerEVP of Finance & AccountingSep 14, 2026
Brian Lee BrownChief Financial OfficerMay 27, 2026
Dwight H EganChief Executive OfficerMay 27, 2026

Recent insider buys & sales

DateInsiderTypeSharesPrice
No open-market insider buys or sales reported in the last 12 months.

CODX financials (annual, from XBRL filings)

Fiscal year endRevenueNet incomeDiluted EPSOperating cash flow
Dec 31, 2025$622.49K$-46.90M-35.25$-29.14M
Dec 31, 2024$3.92M$-37.64M-37.22$-29.16M
Dec 31, 2023$6.81M$-35.33M-1.20$-22.08M
Dec 31, 2022$34.22M$-14.24M-0.45$6.57M
Dec 31, 2021$97.89M$36.66M1.23$41.08M

Latest balance sheet: total assets $16.59M, total liabilities $3.88M, cash $3.65M (as of Jun 30, 2026).

CODX earnings / results-day log

DateFilingClose that day
Aug 13, 20268-K Item 2.02 (results)$1.49
May 14, 20268-K Item 2.02 (results)$1.63
Mar 31, 20268-K Item 2.02 (results)$1.86
Mar 10, 20268-K Item 2.02 (results)$4.40
Nov 13, 20258-K Item 2.02 (results)$11.16
Aug 14, 20258-K Item 2.02 (results)$7.95
May 8, 20258-K Item 2.02 (results)$10.65
Mar 27, 20258-K Item 2.02 (results)$11.76
Nov 7, 20248-K Item 2.02 (results)$35.40
Aug 8, 20248-K Item 2.02 (results)β€”
May 9, 20248-K Item 2.02 (results)β€”
Mar 14, 20248-K Item 2.02 (results)β€”

Related stocks Β· Surgical & Medical Instruments & Apparatus

Boston Scientific (BSX)Stryker (SYK)3M (MMM)Dexcom (DXCM)Becton Dickinson (BDX)Medline (MDLN)MiniMed (MMED)Resmed (RMD)Insulet (PODD)West Pharmaceutical Services (WST)

Popular today

Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)Space Exploration Technologies (SPCX)AMD (AMD)Apple (AAPL)Tesla (TSLA)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)

More on CODX

Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 15, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.